Precision medicine, an approach that tailors medical treatment to the individual characteristics of each patient, is being revolutionized by the integration of artificial intelligence (AI) and deep learning. This chapter explores the application of deep learning for the fusion of genomic and clinical data, a critical challenge in realizing the full potential of precision medicine. We introduce a novel multi-modal fusion network (MMFN) designed to integrate high-dimensional genomic data with structured clinical information for improved patient outcome prediction. The proposed architecture leverages specialized modules for genomic and clinical feature extraction, a sophisticated attention mechanism for data fusion, and a robust prediction module. Using The Cancer Genome Atlas (TCGA) pan-cancer dataset, we demonstrate that our MMFN significantly outperforms traditional machine learning models and unimodal deep learning approaches in predicting patient survival. The chapter details the complete methodology, from data preprocessing to model evaluation, and provides a comprehensive discussion of the results, including performance metrics, feature importance analysis, and model interpretability. We conclude by discussing the implications of our findings for the future of AI-powered precision medicine and outline potential avenues for future research.